Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1999
06/16/1999EP0921801A1 Inhibitors of farnesyl-protein transferase
06/16/1999EP0921800A1 Substituted biphenyl isoxazole sulfonamides
06/16/1999EP0863897B1 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4- or h3-receptor ligands
06/16/1999EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
06/16/1999CN1219968A Antibodies to ED-8 domain of fibronectin, their construction and uses
06/16/1999CN1219965A Promotion of regeneration of organized tissues
06/16/1999CN1219936A New triazolopurines, method of preparing them and their use as drugs
06/16/1999CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
06/16/1999CN1219929A Urea derivatives as inhibitors of IMPDH enzyme
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219875A Hexahydro-pyrido (4,3-B) indole derivatives as antipsychotic drugs
06/16/1999CN1219874A Preparation for percutaneous administration
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219871A Method of regulating skin appearance with vitamin B3 compound
06/16/1999CN1219533A Sulfonamide-substituted fused 5-membered ring compounds, their use as medicament, and pharmaceutical preparation comprising them
06/16/1999CN1043645C New benzothiadiazine compound, process for its preparation and pharmaceutical compositions which contain it
06/16/1999CN1043643C Cyclohexan derivative and its use for preparing medicine
06/16/1999CN1043640C Process for preparing oxazolyl derivatives
06/16/1999CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912357 Enzyme inhibitors
06/15/1999US5912348 Isomerization promoted with bases
06/15/1999US5912346 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
06/15/1999US5912273 Triphenylethylenes compositions
06/15/1999US5912270 Anti-inflammatory compounds
06/15/1999US5912265 Administering silymarin, silybin, silidianin, silicristin, dehydrosilybin or mixtures; antitumor and anticarcinogenic agents
06/15/1999US5912260 Gastrin and CCK antagonists
06/15/1999US5912259 Nonsteroid antiinflammatory agents for nervous system disorders
06/15/1999US5912257 Two-photon upconverting dyes and applications
06/15/1999US5912252 Compounds as enzyme inhibitors of purine nucleoside phosphorylase
06/15/1999US5912251 Metabolically inert anti-inflammatory and anti-tumor antifolates
06/15/1999US5912235 Ring-contracted n-demethyl-n-isopropyl-erythromycin-a-spiroacetal compounds, gastrointestinally effective motilin-agonistic properties
06/15/1999US5912228 Mixture with ethylene oxide-propylene oxide block copolymer and ethylenediaminetetraacetic acid
06/15/1999US5912159 An isolated human polypeptide which controls nitric oxide biosynthesis; diagnosis and therapy for urea cycle diseases, hypertension, hypotension, prostate cancer/ hyperplasia/ hypertrophy and kidney diseases
06/15/1999US5912122 A polynucleotide coding for a central nervous system g protein receptor; therapy for neurodegenerative disorders
06/15/1999US5912005 Methods of use of uncoated gel particles
06/15/1999US5911997 Relaxin-like factor and methods and uses thereof
06/15/1999US5911994 Extract from Salvia officinalis for use in the treatment of Dupuytrens's contracture
06/15/1999CA2191947C Pirydyl imidazole derivatives and processes for the preparation thereof
06/15/1999CA2182477C Pyridyl imidazole derivatives and processes for the preparation thereof
06/15/1999CA2161641C Stable, ingestable and absorbable nadh and nadph therapeutic compositions
06/15/1999CA2155664C Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents
06/15/1999CA2136821C Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
06/15/1999CA2001083C Novel s-timolol derivative and process for its preparation
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028473A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028472A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
06/10/1999WO1999028348A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
06/10/1999WO1999028346A1 Erythropoietin with high specific activity
06/10/1999WO1999028343A2 Hydrophobically-modified protein compositions and methods
06/10/1999WO1999028325A1 Thienopyrimidines
06/10/1999WO1999028324A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
06/10/1999WO1999028318A1 Amino-benzothiazole derivatives
06/10/1999WO1999028316A1 Thiophene-sulfonamide compounds
06/10/1999WO1999028315A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
06/10/1999WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
06/10/1999WO1999028309A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
06/10/1999WO1999028306A1 Benzenesulfonamide compounds
06/10/1999WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
06/10/1999WO1999028300A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999WO1999027953A1 Chemoprotective bacterial strains
06/10/1999WO1999027949A1 METHOD OF SUPPRESSING β-AMYLOID-RELATED CHANGES IN ALZHEIMER'S DISEASE
06/10/1999WO1999027937A2 Method for inhibiting cytokine production by cells
06/10/1999WO1999027936A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027935A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027931A1 USE OF BICOZAMYCIN FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING INFECTIONS WITH ENTEROHEMORRHAGIC $i(E. COLI)
06/10/1999WO1999027930A1 Thrombin inhibitors
06/10/1999WO1999027919A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods
06/10/1999WO1999027906A1 Long acting injectable formulations containing hydrogenated castor oil
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999008684A3 Solutions containing azasteroids
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999WO1998040080A9 Oxyalkylene phosphate compounds and uses thereof
06/10/1999DE19754573A1 Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma A pharmaceutical composition for the treatment of stroke and traumatic brain injury
06/10/1999DE19754082A1 Methode zur Bekämpfung der Fettleibigkeit Method to combat obesity
06/10/1999CA2313050A1 Amino-benzothiazole derivatives
06/10/1999CA2312851A1 Therapeutic and diagnostic methods dependent on cyp2a enzymes
06/10/1999CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders
06/10/1999CA2312334A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999CA2312023A1 Method for inhibiting cytokine production by cells
06/10/1999CA2311929A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
06/10/1999CA2311613A1 Chemoprotective bacterial strains
06/10/1999CA2311574A1 Cells expressing anti-fc receptor binding components
06/10/1999CA2310629A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
06/10/1999CA2310054A1 Thiophene-sulfonamide compounds
06/10/1999CA2310008A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
06/10/1999CA2309969A1 Benzenesulfonamide compounds
06/10/1999CA2309810A1 Erythropoietin with high specific activity
06/10/1999CA2309806A1 Hydrophobically-modified protein compositions and methods
06/10/1999CA2309347A1 Thrombin inhibitors
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0921130A2 Steroid sulphatase inhibitors
06/09/1999EP0921120A1 Selective beta 3 adrenergic agonists
06/09/1999EP0921119A1 Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
06/09/1999EP0921116A1 N-(4-carbamimido-phenyl)-glycine amide derivatives
06/09/1999EP0920870A1 Flavanone-containing composition
06/09/1999EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
06/09/1999EP0920865A1 Pharmaceutical compositions containing Norastemizole
1 ... 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 ... 1564